| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19804bb15f463e7b9a25b0c129604408
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b7c08085555fac4cc883cf1ea1e4d66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5280b5c2e4d4bb68735cc9a085214c0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb880bf0b32905833d71c570286c8ded |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| filingDate |
2005-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2106dbadf9e374cb3503e9a059c57f3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21255baf6430b9c969b3bedbb039e674
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_677add078e952d08355478eb58c859ea |
| publicationDate |
2006-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006007697-A1 |
| titleOfInvention |
Methods or use of lamin b1 nuclear antigen, fragments and compositions thereof, for inhibiting or reducing a thrombotic event |
| abstract |
A method for preventing a thrombotic event in a patient susceptible to such an event, which comprises the step of administering an effective amount of a lamin 131 nuclear (LB1) antigen to said patient is provided along with an anti-thrombotic composition which comprises an effective amount of a lamin 131 nuclear (LB1) antigen and a pharmaceutically acceptable carrier. |
| priorityDate |
2004-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |